Efficacy and safety of pilocarpine mouthwash in elderly patients with xerostomia.

OBJECTIVE Xerostomia is a common condition and can impair quality of life. Pilocarpine tablet ingestion can relieve dry mouth symptoms, but produces numerous adverse effects. We investigated the safety and efficacy of pilocarpine mouthwash. METHODS Forty elderly patients were randomly divided into a pilocarpine mouthwash or water rinse (control) group. Outcomes were assessed by visual analog scale (VAS) scores and stimulated salivary flow rate before and 1 month after treatment. Patients recorded all adverse effects. RESULTS In the pilocarpine group, we evaluated safety in 24 patients and efficacy in 19 patients. In the water rinse group, we evaluated safety and efficacy in 14 patients. VAS scores were significantly reduced after pilocarpine mouthwash treatment (70 ± 12.9 to 47.9 ± 13.1, p < 0.05). Overall improvement was observed in 47% of the pilocarpine group compared to 14% of the controls (p < 0.05). Stimulated salivary flow rate significantly increased (0.71 ± 0.14 to 0.83 ± 0.12 mL/minute, p < 0.05) after pilocarpine mouthwash treatment. Five of 24 patients reported side effects after pilocarpine mouthwash use, predominantly limited to oral discomfort. CONCLUSIONS Pilocarpine mouthwash relieved dry mouth symptoms and improved saliva production with minor side effects.

[1]  J. H. Kim,et al.  Effect of 0.1% pilocarpine mouthwash on xerostomia: double-blind, randomised controlled trial. , 2014, Journal of oral rehabilitation.

[2]  S. Ishimoto,et al.  Non-invasive objective evaluation of radiotherapy-induced dry mouth. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[3]  D. Birkhed,et al.  Simplified methods of topical fluoride administration: effects in individuals with hyposalivation. , 2013, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[4]  Ram,et al.  Xerostomia: Dental Implications And Management , 2010 .

[5]  M. Behr,et al.  Saliva substitutes for the treatment of radiation-induced xerostomia—a review , 2009, Supportive Care in Cancer.

[6]  K. Ohtomo,et al.  Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese. , 2009, Auris, nasus, larynx.

[7]  J. Y. Wick.  Xerostomia: causes and treatment. , 2007, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

[8]  J. Gibson,et al.  A controlled release pilocarpine buccal insert in the treatment of Sjögren's syndrome , 2007, BDJ.

[9]  J. Ship,et al.  A comparison of the effects of 2 commercially available nonprescription mouthrinses on salivary flow rates and xerostomia. , 2005, Quintessence international.

[10]  T. Nishihara,et al.  Usefulness of new wetness tester for diagnosis of dry mouth in disabled patients. , 2004, Gerodontology.

[11]  M. Greenberg,et al.  Pilocarpine toxicity and the treatment of xerostomia. , 2004, The Journal of emergency medicine.

[12]  G. R. Davies,et al.  An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia. , 2002, Australian dental journal.

[13]  H. M. Barros,et al.  Effect of pilocarpine mouthwash on salivary flow. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[14]  D. Passali,et al.  Efficacy and safety of ketoprofen lysine salt mouthwash versus benzydamine hydrochloride mouthwash in acute pharyngeal inflammation: a randomized, single-blind study. , 2001, Clinical therapeutics.

[15]  F. Vivino,et al.  Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. , 1999, Archives of internal medicine.

[16]  J. Johnson,et al.  Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. , 1995, International journal of radiation oncology, biology, physics.

[17]  A. Davies,et al.  A comparison of artificial saliva and pilocarpine in radiation induced xerostomia , 1994, The Journal of Laryngology & Otology.

[18]  J. Rieke,et al.  A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.